Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Louisville Metabolic and Atherosclerosis Research Center (L-MARC) is a premier clinical research facility based in Louisville, Kentucky, specializing in the study of metabolic and cardiovascular diseases. Founded in 1986 by Dr. Harold Bays, the center has established a global reputation for excellence in conducting human clinical trials, having participated in over 700 studies for major pharmaceutical and biotechnology sponsors. L-MARC provides comprehensive services including participant recruitment, on-site study execution, and regulatory compliance, with deep expertise in lipid disorders, obesity medicine, and diabetes. In December 2025, the company was acquired by Monroe Biomedical Research, a leading clinical trial site network, to expand its therapeutic reach and geographic footprint.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Atherosclerosis Research Center.